ATE269099T1 - Bpi-protein-produkte für definierte funktionen des reticuloendothelialen systems - Google Patents

Bpi-protein-produkte für definierte funktionen des reticuloendothelialen systems

Info

Publication number
ATE269099T1
ATE269099T1 AT94930656T AT94930656T ATE269099T1 AT E269099 T1 ATE269099 T1 AT E269099T1 AT 94930656 T AT94930656 T AT 94930656T AT 94930656 T AT94930656 T AT 94930656T AT E269099 T1 ATE269099 T1 AT E269099T1
Authority
AT
Austria
Prior art keywords
reticuloendothelial system
bpi protein
protein products
defined functions
system function
Prior art date
Application number
AT94930656T
Other languages
English (en)
Inventor
Leeuwen Paul A M Van
Marja A Boermeester
Original Assignee
Xoma Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Technology Ltd filed Critical Xoma Technology Ltd
Application granted granted Critical
Publication of ATE269099T1 publication Critical patent/ATE269099T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94930656T 1993-10-15 1994-10-05 Bpi-protein-produkte für definierte funktionen des reticuloendothelialen systems ATE269099T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13251093A 1993-10-15 1993-10-15
PCT/US1994/011404 WO1995010297A1 (en) 1993-10-15 1994-10-05 Method of treating depressed reticuloendothelial system function

Publications (1)

Publication Number Publication Date
ATE269099T1 true ATE269099T1 (de) 2004-07-15

Family

ID=22454373

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94930656T ATE269099T1 (de) 1993-10-15 1994-10-05 Bpi-protein-produkte für definierte funktionen des reticuloendothelialen systems

Country Status (7)

Country Link
EP (1) EP0722333B1 (de)
AT (1) ATE269099T1 (de)
AU (1) AU7970894A (de)
CA (1) CA2173611C (de)
DE (1) DE69433848T2 (de)
WO (1) WO1995010297A1 (de)
ZA (1) ZA947783B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5643875A (en) * 1994-01-24 1997-07-01 Friedmann; Nadav Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products
US5447913A (en) * 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
WO1997004008A1 (en) * 1995-07-20 1997-02-06 Xoma Corporation Anti-fungal peptides
US5741779A (en) * 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
PT914144E (pt) * 1996-05-10 2001-05-31 Univ Texas Utilizacoes terapeuticas de produtos de proteinas bip contra a meningococcemia humana
CA2255539C (en) * 1996-05-23 2005-09-27 Xoma Corporation Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma
US5888973A (en) 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US6013631A (en) * 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
EP1741440A1 (de) 2005-07-08 2007-01-10 Mellitus S.L. Verwendung von BPI-proteine zur Behandlung von stoffwechselbedingten Erkrankungen und Herzkreislaufstörungen
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
GB201319621D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234912A (en) * 1989-02-14 1993-08-10 Incyte Pharmaceuticals, Inc. Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
US5171739A (en) * 1989-02-14 1992-12-15 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
ES2123134T3 (es) * 1993-03-12 1999-01-01 Xoma Corp Peptidos biologicamente activos de dominios funcionales de la proteina bactericida aumentadora de la permeabilidad y usos de los mismos.

Also Published As

Publication number Publication date
HK1014498A1 (en) 1999-09-30
EP0722333A1 (de) 1996-07-24
DE69433848D1 (de) 2004-07-22
WO1995010297A1 (en) 1995-04-20
DE69433848T2 (de) 2005-05-25
EP0722333B1 (de) 2004-06-16
ZA947783B (en) 1996-05-05
AU7970894A (en) 1995-05-04
CA2173611A1 (en) 1995-04-20
CA2173611C (en) 2005-07-26

Similar Documents

Publication Publication Date Title
DE69433848D1 (de) Bpi-protein-produkte für definierte funktionen des reticuloendothelialen systems
MX9602570A (es) Metodos y materiales anti-fungosos.
EP0749080A3 (de) System zum Vewalten von Bestellungen
ES2119185T3 (es) Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad.
DE69435116D1 (de) Verwendung von Botulinumtoxin für die Herstellung eines Arzneimittels zur Linderung von Rückenschmerzen
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE69727142D1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
ZA969130B (en) Diagnostics and treatments of periodontal disease
PT845998E (pt) Medicamentos para imunoterapia contendo anticorpos que reconhecem de forma especifica o antigenio mhcii de um paciente a ser tratado
ZA955740B (en) Anti-protozoan methods and materials
WO1998006415A3 (en) Anti-chlamydial methods and materials
NZ332954A (en) Use of BPI protein products to treat humans with hemorrhage due to trauma
MX9602442A (es) Un tratamiento con fluoroquinolona a dosis unica elevada.
TR199800717T2 (xx) Amyotrofik lateral skleroz tedavisine y�nelik ila� haz�rlamak i�in
MY115014A (en) Mouth-care products
ATE207079T1 (de) Produkt aus von beta-cesein wesentlich freier milch aus nicht-menschlichen sängetieren und dessen verwendung
MY113431A (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE69636907D1 (de) Verwendung von lezithin-cholesterin-azetyltransferase für die behandlung von atherosklerose
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
IL126161A0 (en) Method for treating autism
ATE259242T1 (de) Cd4-derivierte peptide die einen immunrespons inhibieren
TR199901998T2 (xx) 9,10-sekokolesta-5,7,10(19)-triyen-1,3-diyol veya alfakasidol�n kullan�m�.
PT741746E (pt) Compostos sinteticos relacionados com a timosina alfa1 e novos metodos para a sua sintese
ATE231887T1 (de) Protein mit anti-tumorwirkung
UA8333A1 (uk) Спосіб лікування септичних захворювань

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties